Sixfold Bioscience is a biotechnology firm focused on advancing RNA therapies founded in 2017 by Anna Perdrix Rosell, Zuzanna Brzosko and George Foot.
Biotechnology firm focused on advancing RNA therapies.
We founded Sixfold to tackle the biggest challenge in RNA therapeutics: how to safely deliver RNA to diseased cells. We’re an inclusive, diverse and highly motivated team of engineers, builders, scientist and operators redefining the future of RNA.
Biotechnology firm focused on advancing RNA therapies.